Prohibitin and its rapidly emerging role as a biomarker of systemic malignancies - Reply

Human Pathology

Volumn 44, Issue 4, 2013, Pages 679-680

  Guo, Feng ^a   Hiroshima, Kenzo ^a   Wu, Di ^a   Satoh, Mamoru ^b   Abulazi, Mayinuer ^b   Nomura, Fumio ^b   Yoshino, Ichiro ^b   Tomonaga, Takeshi ^c   Nakatani, Yukio ^b  

^a Tokyo Women s Medical University   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROHIBITIN; PROTEIN KINASE B; PROTEIN P53; RAF PROTEIN;

BLADDER CANCER; BREAST CANCER; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; COLORECTAL CANCER; DIAGNOSTIC VALUE; DISEASE MARKER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LUNG SQUAMOUS CELL CARCINOMA; MITOCHONDRIAL MEMBRANE; NEOPLASM; PROSTATE CANCER; PROTEIN BINDING; PROTEIN LOCALIZATION; STOMACH CANCER; SYSTEMIC DISEASE; TUMOR CELL;

CARCINOMA, SQUAMOUS CELL; HUMANS; LUNG; LUNG NEOPLASMS; MITOCHONDRIA; REPRESSOR PROTEINS;

EID: 84875197785     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.12.008     Document Type: Letter

References (11)

1. F. Guo, K. Hiroshima, and D. Wu Prohibitin in squamous cell carcinoma of the lung: its expression and possible clinical significance Hum Pathol 43 2012 1282 1288
2. K.J. Wang, R.T. Wang, and J.Z. Zhang Identification of tumor markers using two-dimensional electrophoresis in gastric carcinoma World J Gastroenterol 10 2004 2179 2183
3. H.Z. Ren, J.S. Wang, and P. Wang Increased expression of prohibitin and its relationship with poor prognosis in esophageal squamous cell carcinoma Pathol Oncol Res 16 2010 515 522
4. E.R. Jupe, X.T. Liu, and J.L. Kiehlbauch Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3′ untranslated region mutations Cell Growth Differ 7 1996 871 878
5. T.F. Wu, H. Wu, and Y.W. Wang Prohibitin in the pathogenesis of transitional cell bladder cancer Anticancer Res 27 2007 895 900
6. R. Ummanni, H. Junker, and U. Zimmermann Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer Cancer Lett 266 2008 171 185
7. J. Mengwasser, A. Piau, and P. Schlag Differential immunization identifies PHB1/PHB2 as blood-borne tumor antigens Oncogene 23 2004 7430 7435
8. G. Fusaro, P. Dasgupta, and S. Rastogi Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling J Biol Chem 278 2003 47853 47861
9. S. Wang, N. Nath, and M. Adlam Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function Oncogene 18 1999 3501 3510
10. S. Mishra, S.R. Ande, and B.L. Nyomba The role of prohibitin in cell signaling FEBS J 277 2010 3937 3946
11. A.L. Theiss, and S.V. Sitaraman The role and therapeutic potential of prohibitin in disease Biochim Biophys Acta 1813 2011 1137 1143